Pacira Biosciences
PCRX
#5836
Rank
NZ$1.86 B
Marketcap
NZ$41.53
Share price
0.04%
Change (1 day)
25.83%
Change (1 year)
Categories

Revenue for Pacira Biosciences (PCRX)

Revenue in 2025 (TTM): NZ$1.23 Billion

According to Pacira Biosciences 's latest financial reports the company's current revenue (TTM ) is NZ$1.24 Billion. In 2024 the company made a revenue of NZ$1.24 Billion an increase over the revenue in the year 2023 that were of NZ$1.06 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Pacira Biosciences from 2010 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) NZ$1.23 B-0.48%
2024 NZ$1.24 B16.45%
2023 NZ$1.06 B1.62%
2022 NZ$1.05 B32.47%
2021 NZ$0.79 B33.15%
2020 NZ$0.59 B-4.75%
2019 NZ$0.62 B24.33%
2018 NZ$0.50 B24.59%
2017 NZ$0.40 B1.15%
2016 NZ$0.39 B9.67%
2015 NZ$0.36 B44.21%
2014 NZ$0.25 B142.33%
2013 NZ$0.10 B119.13%
2012 NZ$47.51 M136.36%
2011 NZ$20.1 M6.49%
2010 NZ$18.87 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Recro Pharma
REPH
NZ$0.13 B-89.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
NZ$0.17 B-85.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
NZ$12.35 M-99.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Heron Therapeutics
HRTX
NZ$0.26 B-78.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
NZ$0.14 B-88.60%๐Ÿ‡บ๐Ÿ‡ธ USA